The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - North Shore Hematology Oncology Associates
Leadership - North Shore Hematology Oncology Associates
Comparison of hydration events in patients (pts) receiving highly (HEC) or moderately (MEC) emetogenic chemotherapy treated with granisetron extended-release subcutaneous (GERSC) or palonosetron (PALO).
 
Jeffrey Vacirca
Stock and Other Ownership Interests - Odonate Therapeutics
Consulting or Advisory Role - HERON; ION Pharma
 
Dennis Caruana
Employment - North Shore Hematology Oncology Associates
Travel, Accommodations, Expenses - Oncopeptides
 
George Calcanes
No Relationships to Disclose
 
Michael Mosier
Consulting or Advisory Role - HERON
 
Ralph V. Boccia
Employment - Center for Cancer and Blood Disorders
Leadership - Center for Cancer and Blood Disorders
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Genentech; Gilead Sciences; HERON; Incyte
Consulting or Advisory Role - Gilead Sciences; HERON; Incyte
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Genentech; Gilead Sciences; HERON; Incyte
Research Funding - Incyte (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Genentech; Gilead Sciences; HERON; Incyte
 
Ali McBride
Consulting or Advisory Role - Takeda; University of Arizona